• Publications
  • Influence
Extended high cut‐off haemodialysis for myeloma cast nephropathy in Auckland, 2008–2012
Treatment with extended high cut‐off haemodialysis coupled with novel anti‐myeloma therapies enables significant reduction of serum‐free light chains and has been shown to improve renal outcomes. Expand
Intensification of blood pressure treatment in Pasifika people with type 2 diabetes and renal disease: a cohort study in primary care.
This community-based programme was effective in lowering BP and urinary ACR and in patients who achieved remission of albuminuria, a slower eGFR decline was observed after 12 months. Expand
A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).
There has been a lot of speculation that patients with coronavirus disease 2019 (COVID-19) who are receiving angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) mayExpand
Presentation, pathology and prognosis of renal disease in type 2 diabetes
Renal disease in patients with T2D is heterogeneous, and the renal prognosis differs markedly according to histopathological diagnosis and mode of presentation. Expand
Proteinuric renal disease in type 2 diabetes-is remission of proteinuria associated with improved mortality and morbidity?
Failure to attain remission of proteinuria was associated with increased risk of ESRD or death, a risk compounded by the presence of severe diabetic retinopathy, and on morbidity and mortality. Expand
Lived Experiences and Long-Term Challenges and Needs of Asian Left Ventricular Assist Device Caregivers
Background: Caregivers are essential for improved outcomes in patients living with left ventricular assist device (LVAD). There is a paucity of research on a long-term LVAD caregivers' experiencesExpand